The Nasdaq Technology Index closed down more than 1.3%, and Trump demanded the pharmaceutical industry increase the transparency of drug risks
Component stocks Rapport Therapeutics fell 20.12%, Anavex Life Sciences dropped 13.50%, BeOne Medicines DRC decreased by 10.68%, and Zai Lab ADR declined 9.81%, ranking fourth from the bottom.
Amylyx Pharmaceuticals rose 12.56%, ranking third, Trevi Therapeutics increased by 14.13%, and Travere Therapeutics surged 26.21%
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments